Wang, Xin http://orcid.org/0000-0002-0322-8970
Ryu, Justine
Kim, Jihoon
Ramirez, Andrea
Mayo, Kelsey R.
Condon, Henry
Vaitinadin, Nataraja Sarma
Ohno-Machado, Lucila
Talavera, Greg A.
Ellinor, Patrick T.
Lubitz, Steven A.
Choi, Seung Hoan
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1RO1HL092577, 1R01HL157635, 1R01HL157635, R01HL139731, R01HL157635)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
American Heart Association (18SFRN34110082)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 8 November 2022
Revised: 23 March 2023
Accepted: 27 March 2023
First Online: 18 April 2023
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: PTE receives sponsored research support from Bayer AG, IBM Research, Bristol Myers Squibb, and Pfizer; he has also served on advisory boards or consulted for Bayer AG and MyoKardia. SAL is a full-time employee of Novartis as of July 18, 2022. SAL has received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM, and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae.